Evidence map›Paper›PMID 32680474›Full record

ArticleBMC medical research methodology2020

WHO Trial Registration Data Set (TRDS) extension for traditional Chinese medicine 2020: recommendations, explanation, and elaboration.

Xuan Zhang, Liang Lan, Jacky C P Chan, Linda L D Zhong, Chung-Wah Cheng, Wai-Ching Lam, Ran Tian, Chen Zhao, Tai-Xiang Wu, Hong-Cai Shang and 2 more

Abstract read
In one paragraph

Article in BMC medical research methodology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xuan ZhangChinese Clinical Trial Registry (Hong Kong), Hong Kong Chinese Medicine Clinical Study Centre, The EQUATOR China Centre, School of Chinese Medicine, Hong Kong Baptist University (HKBU), Room 307, Jockey Club School of Chinese Medicine Building, 7 Baptist University Road, Kowloon Tong, Kowloon, HKSAR, China.
Liang LanDepartment of Computer Science, HKBU Faculty of Science, Hong Kong Baptist University, Hong Kong, SAR, China.
Jacky C P ChanDepartment of Computer Science, HKBU Faculty of Science, Hong Kong Baptist University, Hong Kong, SAR, China.
Linda L D ZhongChinese Clinical Trial Registry (Hong Kong), Hong Kong Chinese Medicine Clinical Study Centre, The EQUATOR China Centre, School of Chinese Medicine, Hong Kong Baptist University (HKBU), Room 307, Jockey Club School of Chinese Medicine Building, 7 Baptist University Road, Kowloon Tong, Kowloon, HKSAR, China.
Chung-Wah ChengChinese Clinical Trial Registry (Hong Kong), Hong Kong Chinese Medicine Clinical Study Centre, The EQUATOR China Centre, School of Chinese Medicine, Hong Kong Baptist University (HKBU), Room 307, Jockey Club School of Chinese Medicine Building, 7 Baptist University Road, Kowloon Tong, Kowloon, HKSAR, China.
Wai-Ching LamChinese Clinical Trial Registry (Hong Kong), Hong Kong Chinese Medicine Clinical Study Centre, The EQUATOR China Centre, School of Chinese Medicine, Hong Kong Baptist University (HKBU), Room 307, Jockey Club School of Chinese Medicine Building, 7 Baptist University Road, Kowloon Tong, Kowloon, HKSAR, China.
Ran TianChinese Clinical Trial Registry (Hong Kong), Hong Kong Chinese Medicine Clinical Study Centre, The EQUATOR China Centre, School of Chinese Medicine, Hong Kong Baptist University (HKBU), Room 307, Jockey Club School of Chinese Medicine Building, 7 Baptist University Road, Kowloon Tong, Kowloon, HKSAR, China.
Chen ZhaoInstitute of Basic Research In Clinical Medicine, China Academy Of Chinese Medical Sciences, Beijing, China.
Tai-Xiang WuChinese Cochrane Centre, West China Hospital, Sichuan University, China Trial Registration Center, Chengdu, Sichuan, China.
Hong-Cai ShangKey Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Ai-Ping LyuChinese Clinical Trial Registry (Hong Kong), Hong Kong Chinese Medicine Clinical Study Centre, The EQUATOR China Centre, School of Chinese Medicine, Hong Kong Baptist University (HKBU), Room 307, Jockey Club School of Chinese Medicine Building, 7 Baptist University Road, Kowloon Tong, Kowloon, HKSAR, China.
Zhao-Xiang BianChinese Clinical Trial Registry (Hong Kong), Hong Kong Chinese Medicine Clinical Study Centre, The EQUATOR China Centre, School of Chinese Medicine, Hong Kong Baptist University (HKBU), Room 307, Jockey Club School of Chinese Medicine Building, 7 Baptist University Road, Kowloon Tong, Kowloon, HKSAR, China. bzxiang@hkbu.edu.hk.ORCID 0000-0001-6206-1958

Funding

81704198 National Natural Science Foundation of ChinaFSFT Foundation, HKSAR, China. NA
6 · The paper itself

Abstract

backgroundAlthough the WHO Trial Registration Data Set (TRDS) has been published for many years, the quality of clinical trial registrations with traditional Chinese medicine (TCM) is still not satisfactory, especially about the inadequate reporting on TCM interventions. The development of the WHO TRDS for TCM Extension 2020 (WHO TRDS-TCM 2020) aims to address this inadequacy.

methodsA group of clinical experts, methodologists, epidemiologists, and editors has developed this WHO TRDS-TCM 2020 through a comprehensive process, including the baseline survey, draft of the initial items, three-round of Delphi survey, solicitation of comments, revision, and finalization.

resultsThe WHO TRDS-TCM 2020 statement extends the latest version (V.1.3.1) of TRDS published in November 2017. The checklist includes 11 extended items (including subitems), namely Source(s) of Monetary or Material Support (Item 4), Scientific Title (Item 10a and 10b), Countries of Recruitment (Item 11), Health Condition(s) or Problem(s) Studied (Item 12), Intervention(s) (Item 13a, 13b and 13c), Key Inclusion and Exclusion Criteria (Item 14), Primary and Key Secondary Outcomes (Item 19 to 20), and Lay Summary (Item B1). For Item 13 (Interventions), three common TCM interventions--i.e., Chinese herbal medicine formulas, acupuncture and moxibustion-are elaborated.

conclusionsThe group hopes that the WHO TRDS-TCM 2020 can improve the reporting quality and transparency of TCM trial registrations, assist registries in assessing the registration quality of TCM trials, and help readers understand TCM trial design.

Indexed as

Medicine, Chinese TraditionalResearch ReportChecklistHumansRegistriesWorld Health OrganizationChinese medicineClinical trial registrationRecommendationTrial registration data set (TRDS)World Health Organization (WHO)

Identifiers

PMID32680474
PMCPMC7367238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.